196 related articles for article (PubMed ID: 27322736)
1. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.
Qin F; Song Z; Chang M; Song Y; Frierson H; Li H
Cancer Lett; 2016 Sep; 380(1):39-46. PubMed ID: 27322736
[TBL] [Abstract][Full Text] [Related]
2. Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells.
Qin F; Song Z; Babiceanu M; Song Y; Facemire L; Singh R; Adli M; Li H
PLoS Genet; 2015 Feb; 11(2):e1005001. PubMed ID: 25658338
[TBL] [Abstract][Full Text] [Related]
3. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
[TBL] [Abstract][Full Text] [Related]
4. Case Study: Landscape of Chimeric RNAs in Bladder Cancer.
Zhu D; Li H
Methods Mol Biol; 2020; 2079():233-241. PubMed ID: 31728975
[TBL] [Abstract][Full Text] [Related]
5. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples.
Nacu S; Yuan W; Kan Z; Bhatt D; Rivers CS; Stinson J; Peters BA; Modrusan Z; Jung K; Seshagiri S; Wu TD
BMC Med Genomics; 2011 Jan; 4():11. PubMed ID: 21261984
[TBL] [Abstract][Full Text] [Related]
6. Landscape characterization of chimeric RNAs in colorectal cancer.
Wu H; Singh S; Xie Z; Li X; Li H
Cancer Lett; 2020 Oct; 489():56-65. PubMed ID: 32534173
[TBL] [Abstract][Full Text] [Related]
7. Recurrent chimeric fusion RNAs in non-cancer tissues and cells.
Babiceanu M; Qin F; Xie Z; Jia Y; Lopez K; Janus N; Facemire L; Kumar S; Pang Y; Qi Y; Lazar IM; Li H
Nucleic Acids Res; 2016 Apr; 44(6):2859-72. PubMed ID: 26837576
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
Timofeeva OA; Zhang X; Ressom HW; Varghese RS; Kallakury BV; Wang K; Ji Y; Cheema A; Jung M; Brown ML; Rhim JS; Dritschilo A
Int J Oncol; 2009 Oct; 35(4):751-60. PubMed ID: 19724911
[TBL] [Abstract][Full Text] [Related]
9. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
[TBL] [Abstract][Full Text] [Related]
10. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
11. Intergenically Spliced Chimeric RNAs in Cancer.
Jia Y; Xie Z; Li H
Trends Cancer; 2016 Sep; 2(9):475-484. PubMed ID: 28210711
[TBL] [Abstract][Full Text] [Related]
12. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
Qin F; Zhang Y; Liu J; Li H
Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
[TBL] [Abstract][Full Text] [Related]
13. The landscape of chimeric RNAs in bladder urothelial carcinoma.
Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H
Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082
[TBL] [Abstract][Full Text] [Related]
14. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing.
Kannan K; Wang L; Wang J; Ittmann MM; Li W; Yen L
Proc Natl Acad Sci U S A; 2011 May; 108(22):9172-7. PubMed ID: 21571633
[TBL] [Abstract][Full Text] [Related]
15. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
[TBL] [Abstract][Full Text] [Related]
16. Characterization of drug-induced splicing complexity in prostate cancer cell line using long read technology.
Chen X; Houten S; Allette K; Sebra RP; Stolovitzky G; Losic B
Pac Symp Biocomput; 2018; 23():8-19. PubMed ID: 29218865
[TBL] [Abstract][Full Text] [Related]
17. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
18. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
[TBL] [Abstract][Full Text] [Related]
19. Fusion transcript detection using spatial transcriptomics.
Friedrich S; Sonnhammer ELL
BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
